Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06791850 · ClinicalTrials.gov registry record · NA
Sustaining Home Heart Failure Palliative Care in Rural Appalachia
A NA study of Heart Failure NYHA Class III and Heart Failure NYHA Class IV, sponsored by West Virginia University.
- Recruiting
- Registry status
- NA
- Development phase
- 208
- Enrollment target
- 1
- Study location
NCT06791850: Recruiting NA study of Heart Failure NYHA Class III and Heart Failure NYHA Class IV, sponsored by West Virginia University.
NCT06791850 is a NA study of Heart Failure NYHA Class III and Heart Failure NYHA Class IV that is actively recruiting participants, run by West Virginia University. The registered enrollment target is 208 participants, below the 822-participant average among 9 other Heart Failure NYHA Class III trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06791850, a NA study of Heart Failure NYHA Class III and Heart Failure NYHA Class IV, is actively recruiting participants, sponsored by West Virginia University.
- RECRUITING
- Registry status
- NA
- Development phase
- 208 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this mixed methods randomized controlled trial is to test the integrated nurse-led intervention bundle for family home care management of end-stage heart failure and palliative care in rural Appalachia. This intervention bundle is designed to address rural disparities in access to health care, with the help of the faith-based nurses and local volunteer visiting neighbors.
Primary Outcome
Measures patients' Heart Failure (HF) status \& physical function status. Each item is scored on a scale from 0 to 4 or 0 to 5, depending on the question. The overall score range is 0-100 with a higher score indicating better HF health status.
Conditions Studied
Interventions
- BEHAVIORAL HF-FamPALhomeCARE
Study Locations (1)
West Virginia
- West Virginia University Hospital - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2028-05-31 |
| Phase | NA |
What NCT06791850 shows while recruiting
NCT06791850 is an interventional study that assigns participants to a tested intervention. The registered 208 participants enrollment target is mid-sized for trials with a published cap, below the 822-participant average among 9 other Heart Failure NYHA Class III trials with a reported enrollment target (75% lower).
The record links to 2 conditions, with Heart Failure NYHA Class III appearing as the primary indexed condition, and to 1 intervention - of which HF-FamPALhomeCARE is the first listed.
NCT06791850 reports a single indexed study location in West Virginia.
Frequently Asked Questions
What is clinical trial NCT06791850 about?
NCT06791850 is a clinical study titled "Sustaining Home Heart Failure Palliative Care in Rural Appalachia". The aim of this mixed methods randomized controlled trial is to test the integrated nurse-led intervention bundle for family home care management of end-stage heart failure and palliative care in rural Appalachia. This intervention bundle is designed to address rural disparities in access to health ...
What is the current status of trial NCT06791850?
This trial is currently recruiting. It is a NA study. The enrollment target is 208 participants. The study started on 2025-04-01. Estimated completion is 2028-05-31.
What conditions does trial NCT06791850 study?
This clinical trial studies the following conditions: Heart Failure NYHA Class III, Heart Failure NYHA Class IV.
What interventions are being tested in trial NCT06791850?
The interventions under investigation include: HF-FamPALhomeCARE (BEHAVIORAL).
Who is sponsoring clinical trial NCT06791850?
This trial is sponsored by West Virginia University, which has 122 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06791850 being conducted?
This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure NYHA Class III
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06791850's enrollment target sits among peer trials
208 6th of 9 higher than 4 of 9 other Heart Failure NYHA Class III trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure NYHA Class III trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
RECRUITING · NA
-
Promoting Well-being and Health in Heart Failure
RECRUITING · NA
-
An Early Feasibility Study Evaluation of an Implant Free Interatrial Shunt to Improve Heart Failure
RECRUITING · NA
-
Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients
RECRUITING · NA
-
PROACTIVE-HF IDE Trial Heart Failure NYHA Class III
ACTIVE NOT RECRUITING · NA
-
Hemodynamic-GUIDEd Management of Heart Failure
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465774 · 208 participants
Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions
- NCT03803332 · 208 participants · NA
A Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Due to Military Sexual Trauma (MST) in Male and Female Military Personnel
- NCT04732065 · 208 participants · Phase 1
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
- NCT05293756 · 208 participants · NA
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI